Streetbeat News

EJH

E-Home Household Service Holdings Ltd

Open

1.17

Mkt cap

221M

Volume

5M

High

1.28

P/E Ratio

-0.01

52-wk high

36.70

Low

1.12

Div yield

N/A

52-wk low

0.52

In Wednesday's after-market session, several consumer discretionary stocks experienced notable price movements. Thunder Power Holdings, Jowell Global, and Kaixin Holdings were among the top gainers, while Levi Strauss saw a significant decline following its Q3 earnings report.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 8:31 pm

In Monday's pre-market session, several consumer discretionary stocks experienced significant movements. Kaixin Holdings (KXIN) and ZHONGCHAO (ZCMD) saw substantial gains, while MEDIROM Healthcare Techs (MRM) and Kaival Brands Innovations (KAVL) experienced declines.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

Los Angeles County reports a doubling of mpox cases, urging vaccinations for high-risk groups. The JYNNEOS vaccine is available at pharmacies and public health clinics. Health officials recommend safe sex practices and testing for symptoms.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:06 pm

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is relevant for investors tracking trading activities and potential impacts on stock prices.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:55 pm

Trading for a company has been halted at 7:50:00 p.m. ET due to pending news. This could indicate significant upcoming announcements that may impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:50 pm

Nike shares surged 7% in pre-market trading following the announcement of Elliott Hill as the new CEO. Other stocks also showed significant pre-market movements, including Banzai International, Battalion Oil, and FedEx, which reported weaker-than-expected results.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 10:00 am

The European Medicines Agency (EMA) has recommended extending the use of the Imvanex vaccine to adolescents aged 12-17. This decision is based on a study showing similar immune responses in adolescents and adults. The vaccine, already authorized for adults in the EU, is crucial for addressing the mpox outbreak in the Democratic Republic of the Congo and other regions. The EMA's recommendation supports WHO's prequalification process, facilitating broader access to the vaccine.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:41 pm

The US government is committed to controlling the Mpox outbreak, which may impact companies involved in vaccine development and distribution.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:49 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.